Teligent Pharma, Inc. recalls Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufacture…

Recall date

November 30, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0295-2022

FDA classification

Class I

Brand / firm

Teligent Pharma, Inc.

Sold / distributed

Distributed to a wholesaler in CO who further distributed Nationwide in the USA

Why it was recalled

Superpotent Drug

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64